Cleopatra Hospital Co (CAI:CLHO) Tariff Resilience Score: 0/10 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:CLHO Cleopatra Hospital Co CAI:CLHO
87 GF Score
Price E£17.43
GF Value E£14.64
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co Tariff Resilience Score?

Cleopatra Hospital Co has the Tariff Resilience Score of 0, which implies that the company might have .

Cleopatra Hospital Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Cleopatra Hospital Co might have .

Cleopatra Hospital Co  (CAI:CLHO) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Cleopatra Hospital Co Tariff Resilience Score Related Terms

CAI:CLHO
87GF Score
Cleopatra Hospital Co CAI:CLHO
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£17.43 is trading 19.1% above its estimated GF Value™ of E£14.64. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • Tariff Resilience Score: 0
  • GF Value™: E£14.64 vs. price of E£17.43 (19.1% above fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
87GF Score

Get the complete analysis for CAI:CLHO

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£17.43
Price
E£14.64
GF Value